Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Capital Leases (2016 - 2018)

Historic Capital Leases for Surgery Partners (SGRY) over the last 5 years, with Q4 2018 value amounting to $25.4 million.

  • Surgery Partners' Capital Leases changed N/A to $25.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $25.4 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Surgery Partners' Capital Leases is $25.4 million.
  • Over the past 5 years, Surgery Partners' Capital Leases peaked at $52.7 million during Q4 2016, and registered a low of $10.3 million during Q3 2015.
  • Over the past 5 years, Surgery Partners' median Capital Leases value was $14.8 million (recorded in 2017), while the average stood at $19.6 million.
  • Its Capital Leases has fluctuated over the past 5 years, first soared by 521.62% in 2015, then surged by 36571.23% in 2016.
  • Quarter analysis of 5 years shows Surgery Partners' Capital Leases stood at $10.8 million in 2014, then grew by 5.22% to $11.3 million in 2015, then skyrocketed by 365.71% to $52.7 million in 2016, then plummeted by 71.94% to $14.8 million in 2017, then skyrocketed by 71.6% to $25.4 million in 2018.
  • Its last three reported values are $25.4 million in Q4 2018, $24.8 million for Q3 2018, and $25.4 million during Q2 2018.